PHARMACEUTICAL SOCIETY OF AUSTRALIA FOUNDATION LTD
Giving Philosophy
The foundation approaches its giving by supporting postgraduate education and research for pharmacists, aiming to elevate practice standards and improve public health outcomes. It values initiatives that demonstrate measurable improvements in medicines safety, patient outcomes, and evidence-based collaborative practice, particularly in specific disease-state management.
Tips for Applicants
Applicants should clearly outline how their proposed postgraduate study aligns with improving medicines safety, patient outcomes, or system-level innovation in disease-state management. Emphasize a specific disease-state focus and demonstrate how the study will contribute to the PSA Foundation's mission to advance health outcomes.
Notable Grants
- In 2021, a grant was awarded to support research on the impact of Pharmacist-delivered immunisations.
- The Foundation supports awards such as the 'PSA Young Pharmacist of the Year' and 'PSA Lifetime Achievement Award' to recognise excellence in pharmacy.
Financial History (1 years)
| Year | Revenue | Expenses | Assets | Surplus |
|---|---|---|---|---|
| 2023 | — | — | — | — |
Community Evidence
External EvidenceIdentity
- GS ID
- AU-ABN-13664665687
- ABN
- 13664665687
- Sector
- health
- Financial Year
- 2023
Focus Areas
Board & Leadership (8)
- board member
- board member
- director
- director
- director
- trustee
- trustee
- trustee
Method
- Match Confidence
- registry
- Cross-references
- 2 datasets
- Match Key
- ABN
- Relationships
- 22
Matched by Australian Business Number (ABN) — high confidence. This entity was found across multiple government datasets using the same ABN.
Data Sources
JusticeHub
External LinkThis entity is also tracked in JusticeHub with 0 interventions and 0 evidence records.
External ecosystem profile linked from GrantScope for additional context. JusticeHub content is maintained separately.
View on JusticeHubDisability Market Context
NDIS LayerThis organisation shows disability-related delivery signals. The strategic question is whether it sits inside a resilient market, a thin market, or a captured market where large providers take most of the money and local alternatives are scarce.